Freenome (FRNM) news
Recent news
Freenome extends drop to session low, down 11%
Freenome (NASDAQ: FRNM) shares fell to a session low on Friday, declining 11% as of 10:30 a.m. ET. The drop comes amid broader market volatility and sector-specific pressures affecting biotechnology and diagnostic firms. The stock has faced increased scrutiny following recent developments in its…
AInvest Wire · 2d agoFreenome - selling securityholders may offer up to 75,188,742 shares of common stock - SEC filing
AInvest Wire · Aug 18, 2026Freenome, Inc.: TD Cowen initiates coverage with buy rating; price target $17
Jefferies has initiated coverage on Freenome Inc. (NASDAQ:FRNM) with a "Buy" rating and a price target of $17.00, representing potential 47% upside from the current stock price of $11.56. The decision follows the company’s recent progress in developing blood-based cancer screening tests, including…
AInvest Wire · Aug 18, 2026Freenome, Inc.: Jefferies initiates coverage with buy rating; target price $17
AInvest Wire · Aug 17, 2026Freenome, Inc.: BTIG initiates coverage with buy rating; price target $17
AInvest Wire · Aug 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.